Zimbabwe has turned down a major US healthcare agreement valued at $367m (272 million pounds) spanning five years due to Washington's insistence on sensitive data.
This move became public after a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "skewed".
An official spokesman later explained that the United States was requesting health data for research and profit but was not willing to share the benefits from future vaccines.
"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged further dialogue to find a deal agreeable to all parties so the nation's vital HIV programme can continue.
Wider Implications
This development follows a similar case in Kenya, where a high court suspended a related health funding agreement following concerns were raised about the security of citizens' health data.
After resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and accountability.
According to reports, Sixteen African countries have so far signed similar agreements, representing more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The money for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"Our nation was requested to provide its genetic material and health information for a long time, with no corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," he stated.
"In essence, our country would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be available to our people if a new health crisis emerge."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining structures previously established through the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to manage future global health emergencies.
"This system is intended to ensure that when a nation contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
The government's concerns over the US deal "are not meant as opposition to America," Mangwana stressed.
"We are open to further discussions with our US partners on how subsequent co-operation could be designed in a manner that respects the sovereignty and interests of each country."
Health Experts Reaction
Medical experts stated it understood the official position, but urged that talks must proceed since a large portion of the country's HIV programmes relied on foreign aid.
"If technical issues arise, such as those relating to information security or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," it said.
The halted deal highlights the ongoing tensions between accepting vital foreign assistance and protecting national sovereignty in an increasingly interconnected world.